Anticoagulation use in rheumatic heart disease-associated atrial fibrillation: a study of real-world practice in Central Australia
This study demonstrates no significant advantage to VKA over DOAC therapy in vAF in a small cohort of RHD patients living in remote Australia. Further investigation is required to optimise treatment strategies in this important group.
Authors
- Gabrielle Freedman
- Sonia Sawant (ORCID: https://orcid.org/0000-0001-5007-6888)
- Anosh Sivashanmugarajah
- Angus Baumann (ORCID: https://orcid.org/0000-0003-4128-7012)
- Chinmay Khandkar (ORCID: https://orcid.org/0000-0002-0201-2262)
- Ana Garcia
- Sally Terrett
Institutions
- The University of Sydney (AU)
- Flinders University (AU)
- Royal Prince Alfred Hospital (AU)
- St Vincent's Hospital Sydney (AU)
- Alice Springs Hospital (AU)
- Imperial College London (GB)
Publication Details
- Journal
- IJC Heart & Vasculature
- Published
- 2025-05-30
- DOI
- https://doi.org/10.1016/j.ijcha.2025.101711
- Citations
- 1
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 1.39